{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.25.7 Amidst Continued Downtrend
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.25.7 today, marking a significant decline amid a sustained negative trend. The stock has underperformed its sector and broader market indices, reflecting ongoing financial and operational pressures.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.26.55 Amidst Weak Financial Metrics
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a fresh 52-week low of Rs.26.55 today, marking a significant milestone in its ongoing price decline. The stock has been under pressure for several sessions, reflecting a challenging phase for the company amid subdued financial performance and market conditions.
Medi Caps Ltd Falls to 52-Week Low Amidst Continued Financial Struggles
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.27.51 today, marking a significant decline in its stock price amid ongoing financial headwinds and subdued market performance.
Medi Caps Ltd Stock Falls to 52-Week Low of Rs.27.55 Amidst Continued Underperformance
Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.27.55 today, marking a significant decline in its stock price amid ongoing financial headwinds and sectoral pressures.
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Medi Caps Ltd is Rated Strong Sell
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Medi Caps Stock Falls to 52-Week Low of Rs.28.45 Amidst Continued Underperformance
Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.28.45 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.
Why is Medi Caps falling/rising?
On 12-Dec, Medi Caps Ltd recorded a slight price increase of 0.74%, closing at ₹32.83, marking a tentative reversal after a period of sustained decline. Despite this modest gain, the stock remains under significant pressure when viewed against broader market benchmarks and its own historical performance.
Medi Caps Sees Revision in Market Assessment Amidst Challenging Financials
Medi Caps, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. The recent shift in analytical perspective highlights concerns across multiple performance parameters, underscoring the company’s current position within a competitive and volatile industry landscape.
Medi Caps Stock Falls to 52-Week Low of Rs.31 Amidst Continued Underperformance
Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.31 today, reflecting ongoing challenges in its financial and market performance. The stock's decline contrasts with broader market gains, highlighting persistent pressures on the company’s valuation and operational metrics.
Medi Caps Stock Falls to 52-Week Low of Rs.31.91 Amidst Continued Underperformance
Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.31.91, marking a significant decline in its stock value over the past year. This development comes amid a backdrop of subdued financial performance and persistent challenges reflected in key metrics.
Medi Caps Stock Falls to 52-Week Low of Rs.32.03 Amidst Continued Underperformance
Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.32.03 today, reflecting ongoing challenges in its financial and market performance. This price level marks a significant point for the stock, which has been underperforming relative to key benchmarks over the past year.
Medi Caps Stock Falls to 52-Week Low of Rs.32.03 Amidst Continued Underperformance
Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.32.03 today, reflecting ongoing challenges in its financial and market performance. This decline comes despite a modest gain over the past two days, underscoring persistent pressures on the stock amid broader market dynamics.
Medi Caps Stock Falls to 52-Week Low of Rs.33.2 Amidst Continued Downtrend
Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.33.2 today, marking a significant point in its ongoing price decline. The stock has experienced a sustained downward trajectory over the past week, reflecting a series of financial and market challenges.
Medi Caps Stock Falls to 52-Week Low of Rs.34.25 Amidst Continued Underperformance
Medi Caps, a company operating in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.34.25 today, marking a significant milestone in its recent trading performance. This decline comes amid a backdrop of subdued financial results and persistent challenges reflected in key operational metrics.
Why is Medi Caps falling/rising?
As of 17-Nov, Medi Caps Ltd's stock price is at 37.75, having increased by 0.67% after two days of decline. Despite this short-term gain, the stock has significantly underperformed year-to-date and over the past year, with declines of 22.56% and 24.06%, respectively, and a notable drop in investor participation.
Medi Caps Q2 FY26: Steep Revenue Decline Triggers Mounting Losses
Medi Caps Ltd., India's second-largest manufacturer of empty hard gelatine capsules, reported a troubling second quarter for FY2026, with net sales plummeting 75.63% year-on-year to ₹2.02 crores and the company sliding deeper into losses with a net loss of ₹1.82 crores. The micro-cap pharmaceutical company, currently valued at ₹48.00 crores, has seen its stock price decline 24.25% over the past year, closing at ₹38.63 on November 13, 2025, reflecting mounting investor concerns about the company's operational viability.
How has been the historical performance of Medi Caps?
Medi Caps has experienced a significant decline in net sales and profitability, with net sales dropping from 69.87 Cr in Mar'22 to 25.47 Cr in Mar'25, resulting in operating losses and negative profits over the same period. The company's total assets also decreased slightly, reflecting ongoing financial challenges.
Why is Medi Caps falling/rising?
As of 12-Nov, Medi Caps Ltd's stock price has risen to Rs 39.15, up 4.34%, but investor participation has declined significantly. Despite outperforming the Sensex in the short term, the stock has a year-to-date decline of 19.69%, indicating volatility and challenges in maintaining investor confidence.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
